MACH7 TECHNOLOGIES LIMITED — Share Issue/Capital Change 2007

Feb 28, 2007

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement. application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99. 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Safety Medical Products Limited

ABN 26 007 817 192

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf{I}$ ⁺Class of ⁺securities issued or to be issued

Options

• $\mathfrak{D}$ Number of ⁺securities issued or to be issued (if known) or maximum number which may be issued
• $\mathfrak{I}$ Principal terms of the *securities (eg, if options, exercise price and expiry date; if partly paid ⁺securities, the amount outstanding and due dates if. +convertible for payment; securities, the conversion price and dates for conversion)

29,915,750 Options currently on issue and a further 23, 457,000 to be issued from the Bonus Options Issue, being a total of 52,614,500 Options in total after the Bonus Options Issue.

Current Options on issue exercisable at 20c each up to and including December 31, 2008. New Options to be issued pursuant to the Bonus Options Issue are exercisable at \$1.00 each up to and including December 31, 2010.

⁺ See chapter 19 for defined terms.

4	Do the securities rank equally in all respects from the date of allotment with an existing class of quoted *securities?	The Options to be issued will rank pari passu in all respects with the existing options.
	If the additional securities do not rank equally, please state: the date from which they do which extent to they the. ٠ participate for the next dividend,
	of (in the case a trust. distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
5	Issue price or consideration	lssue.	\$0.20 per option for the options currently on issue. \$1.00 per option for the options to be issued under the Bonus Options
6	Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)	Bonus Options Issue.
7	Dates of entering + securities into uncertificated holdings or despatch of certificates	27 th March 2007
8	Number and †class of all	Number A total of 29,915,750	+ Class Ordinary
	*securities quoted ASX. $\circ$ on (including the securities in clause 2 if applicable)	options currently on issue. οf which 15,635,750 are currently listed on the
		ASX, plus a further $23,457,00$ options that
		will issued be
		pursuant to the Bonus
		Options Issue.

⁺ See chapter 19 for defined terms.

$\mathbf{Q}$ Number and ⁺class of all *securities not quoted on ASX (including the securities in clause 2 if applicable)

Number	+ Class
14,280,000	Options

Dividend policy (in the case of a $\sqrt{\frac{1}{1 + \frac{1}{1}}$ Not currently applicable $10$ trust, distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue

• $11$ Is security holder approval $N/A$ required?
• $12²$ Is the issue renounceable or non- $\overline{N/A}$ renounceable?
• 13 Ratio in which the *securities will $N/A$ be offered
• ⁺Class of ⁺securities to which the $14$ $N/A$ offer relates
• $15$ ⁺Record date determine $N/A$ $\mathbf{r}$ entitlements
• Will holdings on different registers 16 (or subregisters) be aggregated for calculating entitlements?
• Policy for deciding entitlements in $17$ $N/A$ relation to fractions
• 18 Names of countries in which the entity has *security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7.

19 Closing date for receipt οf acceptances or renunciations

$N/A$

$N/A$

$N/A$

$+$ See chapter 19 for defined terms.

Appendix 3B New issue announcement

20	Names of any underwriters	N/A
21	Amount of any underwriting fee or	N/A
	commission
22	Names of any brokers to the issue	N/A
23.	Fee or commission payable to the	N/A
	broker to the issue
24.	Amount of any handling fee payable	N/A
	to brokers who lodge acceptances renunciations on behalf of оr
	*security holders
25.	issue is contingent If the on *security holders' approval, the date	N/A
	of the meeting
26	Date entitlement and acceptance	N/A
	form and prospectus or Product Disclosure Statement will be sent to
	persons entitled
27.	If the entity has issued options, and	N/A
	the terms entitle option holders to
	participate on exercise, the date on which notices will be sent to option
	holders
28	Date rights trading will begin (if	N/A
	applicable)
29	Date rights trading will end (if	N/A
	applicable)
30	How do + security holders sell their	N/A
	entitlements in full through a
	broker?
31	How do *security holders sell part	N/A
	broker and accept for the balance?
	of their entitlements through a

⁺ See chapter 19 for defined terms.

32 How do *security holders dispose of $N/A$ their entitlements (except by sale through a broker)?

33 ⁺Despatch date

-

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of securities (tick one)

$(b)$

• Securities described in Part 1 $(a)$ ⊠
• All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

				Tick to indicate you are providing the information or
documents

To be provided in due course

• 35 If the *securities are *equity securities, the names of the 20 largest holders of the ⊠ additional *securities, and the number and percentage of additional *securities held by those holders
• If the *securities are *equity securities, a distribution schedule of the additional 36 ⊠ *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5.001 - 10.000$ $10.001 - 100.000$ 100,001 and over

37

A copy of any trust deed for the additional ⁺securities

⁺ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

38	Number of securities for which + quotation is sought	N/A
39	Class of + securities for which quotation is sought	N/A
40.	Do the securities rank equally in all respects from the date of allotment with an existing + class of quoted securities? If the additional securities do not	N/A
	rank equally, please state: the date from which they do ٠ to which extent the i they ۰ participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not ۰ rank equally, other than in relation to the next dividend. distribution or interest payment
41	Reason for request for quotation now Example: In the case of restricted securities, end of restriction period	N/A
	issued upon conversion (ii) οf another security, clearly identify that other security)
42	Number and class of all securities quoted on ASX (including the securities in clause 38)	Number N/A	+ Class

⁺ See chapter 19 for defined terms.

Ouotation agreement

• $\mathbf{I}$ *Quotation of our additional *securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
• $\overline{\mathcal{L}}$ We warrant the following to ASX.
• The issue of the *securities to be quoted complies with the law and is not $\bullet$ for an illegal purpose.
• There is no reason why those *securities should not be granted *quotation.
• An offer of the "securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give thie warrante

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
• If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the *securities be quoted.
• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
• $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before *quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:	Date:	01.03.07
	Director
	Marcus Boland
Print name:
	SAAAAA SAAAAA

⁺ See chapter 19 for defined terms.